Changes in protein expression in p53 deleted spontaneous thymic lymphomas

被引:21
作者
Honoré, B
Vorum, H
Pedersen, AE
Buus, S
Claësson, MH
机构
[1] Aarhus Univ, Dept Med Biochem, DK-8000 Aarhus C, Denmark
[2] Univ Copenhagen, Panum Inst, Dept Med Microbiol & Immunol, Copenhagen, Denmark
[3] Univ Copenhagen, Panum Inst, Dept Med Anat, Copenhagen, Denmark
关键词
p53; thymic lymphomas; protein; 2D-PAGE; tumor antigens; mass spectrometry;
D O I
10.1016/j.yexcr.2003.11.029
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
By the use of high-resolution two-dimensional gel electrophoresis and computerized image analysis we investigated and compared the expression of cellular proteins from p53 positive (+/+) mouse thymocytes, p53-/- thymocytes before neoplastic transformation, and from cell lines derived from two spontaneous p53-/- thymic lymphomas, SM5 and SM7. A total of around 1500 proteins were detected on individual eels. Only changes in protein expression by a factor of 2 or more were considered. In the thymic lymphoma cells 3-5% of the proteins were found to be differentially regulated when compared with the protein expression in p53+/+ and p53-/- thymocytes. Only a minority (13 proteins) of the quantitatively changed proteins were common for the two thymic lymphoma cell lines, suggesting that the p53 deficiency mainly results in genetic dysfunctions which are individual for a given tumor. Two of the detected proteins increased their expression levels by more than 10 times from the p53+/+ to the p53-/- thymocytes and these high expression levels were also found in thymic lymphomas. The two proteins were identified by mass spectrometry as acidic ribosomal phosphoprotein PO and a 33-kDa protein with a primary structure containing motifs of the glyoxalase-bleomycin resistance protein family (MDR) as deduced from the cDNA. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:91 / 101
页数:11
相关论文
共 34 条
[1]  
Andersen Marie Louise, 2003, J Immune Based Ther Vaccines, V1, P1, DOI 10.1186/1476-8518-1-1
[2]   Self-peptides with intermediate capacity to bind and stabilize MHC class I molecules may be immunogenic [J].
Andersen, MLM ;
Ruhwald, M ;
Nissen, MH ;
Buus, S ;
Claesson, MH .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2003, 57 (01) :21-27
[3]   A comparison of selected mRNA and protein abundances in human liver [J].
Anderson, L ;
Seilhamer, J .
ELECTROPHORESIS, 1997, 18 (3-4) :533-537
[4]  
BARNARD GF, 1992, CANCER RES, V52, P3067
[5]   Cancer chemoresistance: the relationship between p53 and multidrug transporters [J].
Bush, JA ;
Li, G .
INTERNATIONAL JOURNAL OF CANCER, 2002, 98 (03) :323-330
[6]   Regulation of the Mdr1 isoforms in a p53-deficient mouse model [J].
Bush, JA ;
Li, G .
CARCINOGENESIS, 2002, 23 (10) :1603-1607
[7]  
DEFROMENTEL CC, 1992, GENE CHROMOSOME CANC, V4, P1
[8]   p53 prevents maturation to the CD4(+)CD8(+) stage of thymocyte differentiation in the absence of T cell receptor rearrangement [J].
Di, JA ;
Lenardo, MJ ;
ZunigaPflucker, JC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (04) :1923-1928
[9]   PARTICIPATION OF P53 CELLULAR TUMOR-ANTIGEN IN TRANSFORMATION OF NORMAL EMBRYONIC-CELLS [J].
ELIYAHU, D ;
RAZ, A ;
GRUSS, P ;
GIVOL, D ;
OREN, M .
NATURE, 1984, 312 (5995) :646-649
[10]   EXPRESSION OF RIBOSOMAL PHOSPHOPROTEIN PO IS INDUCED BY ANTITUMOR AGENTS AND INCREASED IN MER- HUMAN TUMOR-CELL LINES [J].
GRABOWSKI, DT ;
PIEPER, RO ;
FUTSCHER, BW ;
DEUTSCH, WA ;
ERICKSON, LC ;
KELLEY, MR .
CARCINOGENESIS, 1992, 13 (02) :259-263